Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Accumulated Expenses (2016 - 2025)

Innospec (IOSP) has disclosed Accumulated Expenses for 16 consecutive years, with $152.3 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 9.93% to $152.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $152.3 million through Dec 2025, down 9.93% year-over-year, with the annual reading at $152.3 million for FY2025, 9.93% down from the prior year.
  • Accumulated Expenses hit $152.3 million in Q4 2025 for Innospec, down from $167.3 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $169.1 million in Q4 2024 to a low of $4.3 million in Q2 2023.
  • Historically, Accumulated Expenses has averaged $80.3 million across 5 years, with a median of $69.0 million in 2022.
  • Biggest YoY gain for Accumulated Expenses was 3576.09% in 2024; the steepest drop was 97.21% in 2024.
  • Year by year, Accumulated Expenses stood at $5.2 million in 2021, then increased by 1.92% to $5.3 million in 2022, then dropped by 13.21% to $4.6 million in 2023, then surged by 3576.09% to $169.1 million in 2024, then dropped by 9.93% to $152.3 million in 2025.
  • Business Quant data shows Accumulated Expenses for IOSP at $152.3 million in Q4 2025, $167.3 million in Q3 2025, and $5.0 million in Q2 2025.